ACSL4 and Genetic thrombotic microangiopathy: As demonstrated in Fig. 5, we detected robust immunostaining of ACSL4 in human ATI seven days post-transplantation (Fig. 5a), as well as in severe thrombotic microangiopathy of native kidney (Fig. 5b).